2026 Memphis Hematologic Malignancies Symposium conference hero image

2026 Memphis Hematologic Malignancies Symposium

Accreditation: 4.50 ABIM MOC II | 4.50 AMA PRA Category 1 Credit™ | 4.50 ACPE Pharmacy | 4.50 Nursing Contact Hours

Venue: Memphis Riverline Hotel, 250 North Main Street, Memphis, TN, 38103, United States

Start Date:
Registration Closed

Official conference page for 2026 Memphis Hematologic Malignancies Symposium.

About 2026 Memphis Hematologic Malignancies Symposium

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

21+

Faculty and committee

Conference program and agenda

Agenda

Saturday, August 22nd, 2026

All timings are in Central Time (CDT, GMT-05:00) time.

07:10 AM - 08:10 AMRegistration, Breakfast, & Exhibits (Non- CME Accredited) - (Heritage Foyer/Heritage III & IV)
08:10 AM - 08:15 AMWelcome
08:15 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities - Dr. Binay Shah - (Heritage I & II)
08:30 AM - 10:00 AMSession 1: Myeloma - (Heritage I & II)

Session Chair: Jason Chandler, MD

08:30 AM - 08:50 AM

CAR-T vs BiTE Therapy Carolina Schinke, MD

08:50 AM - 09:10 AM

Whether to transplant or not to transplant Jason Chandler, MD

09:10 AM - 09:30 AM

Using MRD to stop maintenance? Abdullah Mohammad Khan, MBBS

09:30 AM - 09:40 AM

Case Presentation Eric Sanji, MD (Fellow)

09:40 AM - 10:00 AM

Case Discussion

Moderators:

Jason Chandler, MD

Panelists:

Abdullah Mohammad Khan, MBBS; Carolina Schinke, MD; Eric Sanji, MD (Fellow)

10:00 AM - 10:10 AMBreak & Exhibits (Non- CME Accredited) - (Heritage I & II)
10:10 AM - 11:40 AMSession 2: Lymphoma - (Heritage I & II)

Session Chair: Jeff Harris, MD

10:10 AM - 10:30 AM

CLL: Time-limited or Continuous? Alaa Altahan, MD

10:30 AM - 10:50 AM

The evolving treatment landscape in relapsed/refractory DLBCL Pallawi Torka, MD

10:50 AM - 11:10 AM

Chemo-free Approach to ALL Emily Curran , MD

11:10 AM - 11:20 AM

Case Presentation Clesheree Stepter, NP

11:20 AM - 11:40 AM

Case Discussion

Moderators:

Jeff Harris, MD

Panelists:

Emily Curran , MD; Pallawi Torka, MD; Alaa Altahan, MD

11:40 AM - 01:10 PMSession 3: Myeloid (Heritage I & II)

Session Chair: Swapna Thota, MD

11:40 AM - 12:00 PM

Who would you currently induce for AML in 2026? Stephen Anthony Strickland, MD

12:00 PM - 12:20 PM

Germline Predisposition for Adults Swapna Thota, MD

12:20 PM - 12:40 PM

Clonal Hematopoiesis and Current Treatment Algorithms Ashwin Kishtagari, MD

12:40 PM - 12:50 PM

Case Presentation Jonathan Blackmon, MD

12:50 PM - 01:10 PM

Case Discussion

Moderators:

Swapna Thota, MD

Panelists:

Stephen Anthony Strickland, MD; Ashwin Kishtagari, MD

01:10 PM - 02:10 PMLunch & Exhibits (Non- CME Accredited) - Heritage III & IV
02:10 PM - 02:10 PMAdjourn

Venue and map

Accreditations and continuing education

Accreditation

Registration and pricing

Exhibitors and sponsorship